Marengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion

PartnershipTriSTAR program candidatePositive

AI Analysis

Summary

Marengo nominates its first drug candidate under the TriSTAR collaboration with Ipsen and advances the program into IND-enabling development. The company hires Saso Cemerski, an industry expert in T-cell engager discovery, as Senior Vice President to expand its immunology pipeline.

Outcome Details

First drug candidate under TriSTAR collaboration nominated and advancing into IND-enabling development

Importance:6/10

Sentiment:

0.60

partnershippipeline_advancementT-cell_engagerIND_enablingtalent_acquisitioncollaboration

Related Companies

$IPN.PA

Read the original article

Published by PR Newswire Pharma on August 4, 2026 11:00 AM

Read Original